HIV-1 transmission among injection drug users leads to novel recombinants circulating in Southern China

AIDS Research and Human Retroviruses

Volumn 30, Issue 10, 2014, Pages 1006-1009

  Zhao, Ke ^a   Du, Juan ^a   Zheng, Wenwen ^a   Yu, Xiao Fang ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINA; DRUG ABUSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INJECTION DRUG USE; MALE; MOSAICISM; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TRANSMISSION; CLASSIFICATION; COMPLICATION; GENETIC RECOMBINATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PHYLOGENY; SUBSTANCE ABUSE; TRANSMISSION; VIROLOGY;

CHINA; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; RECOMBINATION, GENETIC; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84907550994     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0036     Document Type: Article

References (15)

1. Teng T and Shao Y: Scientific approaches to AIDS prevention and control in China. Adv Dent Res 2011;23(1):10-12.
2. Beyrer C, Razak MH, Lisam K, et al.: Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000;14(1):75-83.
3. Chu TX, Levy JA. Injection drug use and HIV/AIDS transmission in China. Cell Res 2005;15(11-12):865-869.
4. Piyasirisilp S, McCutchan FE, Carr JK, et al.: A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000;74(23):11286-11295.
5. Yu XF, Liu W, Chen J, et al.: Maintaining low HIV type 1 env genetic diversity among injection drug users infected with a B/C recombinant and CRF01AE HIV type 1 in southern China. AIDS Res Hum Retroviruses 2002;18(2): 167-170.
6. Qi H, Zhao K, Xu F, et al.: HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China. PLoS One 2013;8(7):e68656.
7. Li L, Chen L, Yang S, et al.: Recombination form and epidemiology of HIV-1 unique recombinant strains identified in Yunnan, China. PLoS One 2012;7(10):e46777.
8. Tamura K, Peterson D, Peterson N, et al.: MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28(10):2731-2739.
9. Laeyendecker O, Zhang GW, Quinn TC, et al.: Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 2005;38(3):356-362.
10. Li L, Chen L, Liang S, et al.: Subtype CRF01AE dominates the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China. J Med Virol 2013; 85(3):388-395.
11. Li L, Sun G, Liang S, et al.: Different distribution of HIV-1 subtype and drug resistance were found among treatment naive individuals in Henan, Guangxi, and Yunnan province of China. PLoS One 2013;8(10):e75777.
12. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73(1):152-160.
13. Wang N, Wei H, Xiong R, et al.: Near full-length genome characterization of a new CRF01AE/CRF08BC recombinant transmitted between a heterosexual couple in Guangxi, China. AIDS Res Hum Retroviruses 2014;30(5): 484-488.
14. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal. Science 2000;288(5463):55-56.
15. Liu TF and Shafer RW: Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis 2006;42(11):1608-1618.